Introduction: Pneumothorax is a common clinical problem. Primary spontaneous pneumothorax (PSP) occurs in otherwise fit young patients, but optimal management is not clearly defined and often results in a long hospital stay. Ambulatory treatment options are available, but the existing data on their efficacy are poor. The Randomised Ambulatory Management of Primary Pneumothorax trial is a multicentre, randomised controlled trial comparing ambulatory management with standard care, specifically designed to safely and effectively reduce hospital stay.

Methods And Analysis: 236 patients with PSP will be recruited from UK hospitals. Patients will be randomised 1:1 to treatment to either the 'Intervention' arm (ambulatory device; Rocket Pleural Vent) or the 'Control' arm (aspiration ± standard chest drain insertion). Patients will be followed up for a total of 12 months to assess recurrence rates. The primary outcome is total length of stay in hospital (including readmissions) up to 30 days postrandomisation. The secondary outcomes are pain and breathlessness scores, air leak measurement and radiological evidence (on CT scanning) of emphysema-like changes, compared with short-term and long-term outcomes, respectively, and health economic analysis.

Ethics And Dissemination: The trial has received ethical approval from the National Research Ethics Service Committee South-Central Oxford A (15/SC/0240).

Trial Registration Number: ISRCTN79151659.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530507PMC
http://dx.doi.org/10.1136/bmjresp-2019-000403DOI Listing

Publication Analysis

Top Keywords

ambulatory management
12
randomised ambulatory
8
management primary
8
primary pneumothorax
8
randomised controlled
8
controlled trial
8
patients will
8
randomised
5
management
4
primary
4

Similar Publications

Background: Of the numerous complications encountered by people with diabetes (PWD), the effect on mental health is concerning. Within mental health, diabetes distress (DD) occurs when a patient has unfavourable emotional stress while managing their condition, which can be managed by coping strategies but are less studied together in Indian settings. So, the present study aimed to determine the proportion of DD and associated factors and coping skills among the PWD.

View Article and Find Full Text PDF

Background: Individuals with metabolic syndrome (MetS) are at a higher risk of developing depressive symptoms, with inflammation hypothesized to mediate this association. This study used data from the National Health and Nutrition Examination Survey (NHANES) (2015-2020) to investigate the relationship between MetS and depression and assess the mediating role of inflammatory markers.

Methods: This cross-sectional study included 20,520 participants.

View Article and Find Full Text PDF

The increasing demand for personalized healthcare, particularly among individuals requiring continuous health monitoring, has driven significant advancements in sensor technology. Wearable, non-continuous monitoring, and non-contact sensors are leading this innovation, providing novel methods for monitoring vital signs and physiological data in both clinical and home settings. However, there is a lack of comprehensive comparative studies assessing the overall functionality of these technologies.

View Article and Find Full Text PDF

Infrared array sensor-based fall detection and activity recognition systems have gained momentum as promising solutions for enhancing healthcare monitoring and safety in various environments. Unlike camera-based systems, which can be privacy-intrusive, IR array sensors offer a non-invasive, reliable approach for fall detection and activity recognition while preserving privacy. This work proposes a novel method to distinguish between normal motion and fall incidents by analyzing thermal patterns captured by infrared array sensors.

View Article and Find Full Text PDF

Photodynamic therapy (PDT) involves the topical application of a photosensitizer and its activation by visible light, leading to the generation of protoporphyrin IX (PpIX) and reactive oxygen species. Daylight photodynamic therapy (dPDT), a variant utilizing natural sunlight as the energy source, enhances procedural flexibility by eliminating the need for specialized equipment. dPDT has been effectively used in dermatology to treat various cutaneous disorders, including neoplastic and infectious diseases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!